Metabolomic and Lipidomic Signatures of Metabolic Syndrome and its Physiological Components in Adults: A Systematic Review

[1]  J. Ferrières,et al.  Metabolomics reveals plausible interactive effects between dairy product consumption and metabolic syndrome in humans. , 2020, Clinical nutrition.

[2]  E. Randell,et al.  Unfavorable Associations Between Serum Trimethylamine N-Oxide and L-Carnitine Levels With Components of Metabolic Syndrome in the Newfoundland Population , 2019, Front. Endocrinol..

[3]  I. Jialal,et al.  Exploratory metabolomics of nascent metabolic syndrome. , 2019, Journal of diabetes and its complications.

[4]  T. Lundstedt,et al.  Metabolomic and lipidomic assessment of the metabolic syndrome in Dutch middle-aged individuals reveals novel biological signatures separating health and disease , 2019, Metabolomics.

[5]  J. Shaw,et al.  High-Throughput Plasma Lipidomics: Detailed Mapping of the Associations with Cardiometabolic Risk Factors. , 2019, Cell chemical biology.

[6]  G. Muscogiuri,et al.  Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome , 2018, Nutrients.

[7]  Dermot F. Reilly,et al.  Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study , 2018, Diabetologia.

[8]  B. Adams-Huet,et al.  Exploratory lipidomics in patients with nascent Metabolic Syndrome. , 2018, Journal of diabetes and its complications.

[9]  O. Melander,et al.  Altered Asparagine and Glutamate Homeostasis Precede Coronary Artery Disease and Type 2 Diabetes , 2018, The Journal of clinical endocrinology and metabolism.

[10]  S. Weisnagel,et al.  Increased body fat mass explains the positive association between circulating estradiol and insulin resistance in postmenopausal women. , 2018, American journal of physiology. Endocrinology and metabolism.

[11]  M. Saklayen.  The Global Epidemic of the Metabolic Syndrome , 2018, Current Hypertension Reports.

[12]  Tommi Suvitaival,et al.  Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men. , 2018, Metabolism: clinical and experimental.

[13]  J. Griffin,et al.  Metabolomics applied to diabetes-lessons from human population studies. , 2017, The international journal of biochemistry & cell biology.

[14]  D. Panagiotakos,et al.  Amino acid profile and metabolic syndrome in a male Mediterranean population: A cross-sectional study. , 2017, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[15]  N. Sheehan,et al.  A Mendelian Randomization Study of Metabolite Profiles, Fasting Glucose, and Type 2 Diabetes , 2017, Diabetes.

[16]  T. Hankemeier,et al.  Metabolomics based markers predict type 2 diabetes in a 14-year follow-up study , 2017, Metabolomics.

[17]  J. Stinear,et al.  Prevalence of metabolic syndrome and metabolic syndrome components in young adults: A pooled analysis , 2017, Preventive medicine reports.

[18]  Tero Aittokallio,et al.  Early metabolic markers identify potential targets for the prevention of type 2 diabetes , 2017, Diabetologia.

[19]  Blandine Comte,et al.  Systems Metabolomics for Prediction of Metabolic Syndrome. , 2017, Journal of proteome research.

[20]  J. Suez,et al.  Personalized microbiome‐based approaches to metabolic syndrome management and prevention , 2017, Journal of diabetes.

[21]  R. Jayawardena,et al.  Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review , 2017, BMC Public Health.

[22]  J. Blangero,et al.  Lipidomics in the Study of Hypertension in Metabolic Syndrome , 2017, Current Hypertension Reports.

[23]  Jean Tichet,et al.  Impact of statistical models on the prediction of type 2 diabetes using non-targeted metabolomics profiling , 2016, Molecular metabolism.

[24]  Amedeo Napoli,et al.  Feature Selection Methods for Early Predictive Biomarker Discovery Using Untargeted Metabolomic Data , 2016, Front. Mol. Biosci..

[25]  M. Patti,et al.  What Have Metabolomics Approaches Taught Us About Type 2 Diabetes? , 2016, Current Diabetes Reports.

[26]  K. Kawecka-Jaszcz,et al.  Association of free testosterone and sex hormone binding globulin with metabolic syndrome and subclinical atherosclerosis but not blood pressure in hypertensive perimenopausal women , 2016, Archives of medical science : AMS.

[27]  E. Seely,et al.  The association between phthalates and metabolic syndrome: the National Health and Nutrition Examination Survey 2001–2010 , 2016, Environmental Health.

[28]  Emma L. Schymanski,et al.  Mass spectral databases for LC/MS- and GC/MS-based metabolomics: state of the field and future prospects , 2016 .

[29]  Erik Schultes,et al.  The FAIR Guiding Principles for scientific data management and stewardship , 2016, Scientific Data.

[30]  Christoph Steinbeck,et al.  MetaboLights: An Open‐Access Database Repository for Metabolomics Data , 2016, Current protocols in bioinformatics.

[31]  Johann A. Gagnon-Bartsch,et al.  Skeletal muscle and plasma lipidomic signatures of insulin resistance and overweight/obesity in humans , 2016, Obesity.

[32]  Ming-Huei Chen,et al.  Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes , 2016, PloS one.

[33]  Oliver Fiehn,et al.  Toward Merging Untargeted and Targeted Methods in Mass Spectrometry-Based Metabolomics and Lipidomics. , 2016, Analytical chemistry.

[34]  Eoin Fahy,et al.  Metabolomics Workbench: An international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools , 2015, Nucleic Acids Res..

[35]  F. Tinahones,et al.  Metabolomic insights into the intricate gut microbial–host interaction in the development of obesity and type 2 diabetes , 2015, Front. Microbiol..

[36]  B. Balkau,et al.  The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation , 2015, Obesity.

[37]  Dave L Dixon,et al.  The CardioMetabolic Health Alliance: Working Toward a New Care Model for the Metabolic Syndrome. , 2015, Journal of the American College of Cardiology.

[38]  H. Guillou,et al.  Effect of obesity and metabolic syndrome on plasma oxysterols and fatty acids in human , 2015, Steroids.

[39]  Eun-Kyoung Kim,et al.  A Metabolomic Approach to Understanding the Metabolic Link between Obesity and Diabetes , 2015, Molecules and cells.

[40]  Arnald Alonso,et al.  Analytical Methods in Untargeted Metabolomics: State of the Art in 2015 , 2015, Front. Bioeng. Biotechnol..

[41]  Alla Karnovsky,et al.  Metabolomics and Diabetes: Analytical and Computational Approaches , 2015, Diabetes.

[42]  M. Rutter,et al.  Associations between sex steroids and the development of metabolic syndrome: a longitudinal study in European men. , 2015, The Journal of clinical endocrinology and metabolism.

[43]  J. Kuk,et al.  Trajectories of Metabolic Syndrome Development in Young Adults , 2014, PloS one.

[44]  Albert Koulman,et al.  Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study , 2014, The lancet. Diabetes & endocrinology.

[45]  Philippe Bardou,et al.  jvenn: an interactive Venn diagram viewer , 2014, BMC Bioinformatics.

[46]  John C Lindon,et al.  The emergent role of metabolic phenotyping in dynamic patient stratification , 2014, Expert opinion on drug metabolism & toxicology.

[47]  I. Duarte,et al.  NMR metabolomics of human blood and urine in disease research. , 2014, Journal of pharmaceutical and biomedical analysis.

[48]  U. Kujala,et al.  Serum metabolic profiles in overweight and obese women with and without metabolic syndrome , 2014, Diabetology & Metabolic Syndrome.

[49]  Jaspinder Kaur.  A Comprehensive Review on Metabolic Syndrome , 2014, Cardiology research and practice.

[50]  Hui Sun,et al.  Metabolomics in diabetes. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[51]  Jennifer R. Harris,et al.  The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies , 2014, BMC Endocrine Disorders.

[52]  J. Nicholson,et al.  Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease. , 2014, Gastroenterology.

[53]  Age K. Smilde,et al.  Reflections on univariate and multivariate analysis of metabolomics data , 2013, Metabolomics.

[54]  Rawi Ramautar,et al.  Human metabolomics: strategies to understand biology. , 2013, Current opinion in chemical biology.

[55]  Adam Kowalczyk,et al.  Plasma Lipid Profiling Shows Similar Associations with Prediabetes and Type 2 Diabetes , 2013, PloS one.

[56]  R. Lehmann.  Diabetes subphenotypes and metabolomics: the key to discovering laboratory markers for personalized medicine? , 2013, Clinical chemistry.

[57]  Hiram Beltrán-Sánchez,et al.  Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010. , 2013, Journal of the American College of Cardiology.

[58]  V. González-Covarrubias.  Lipidomics in longevity and healthy aging , 2013, Biogerontology.

[59]  P. Schmitt‐Kopplin,et al.  Liquid chromatography-mass spectrometry in metabolomics research: mass analyzers in ultra high pressure liquid chromatography coupling. , 2013, Journal of chromatography. A.

[60]  T. Pischon,et al.  The potential use of biomarkers in the prevention of Type 2 diabetes , 2013, Expert review of endocrinology & metabolism.

[61]  Juan Antonio Vizcaíno,et al.  Shorthand notation for lipid structures derived from mass spectrometry , 2013, Journal of Lipid Research.

[62]  L. Almasy,et al.  Variability in Associations of Phosphatidylcholine Molecular Species with Metabolic Syndrome in Mexican–American Families , 2013, Lipids.

[63]  Christian Gieger,et al.  Novel biomarkers for pre-diabetes identified by metabolomics , 2012, Molecular systems biology.

[64]  D. Noto,et al.  Evaluation of nitric oxide metabolites in a group of subjects with metabolic syndrome. , 2012, Diabetes & metabolic syndrome.

[65]  Susan Cheng,et al.  Metabolite Profiling Identifies Pathways Associated With Metabolic Risk in Humans , 2012, Circulation.

[66]  C. Newgard.  Interplay between lipids and branched-chain amino acids in development of insulin resistance. , 2012, Cell metabolism.

[67]  L. Lind,et al.  Circulating Levels of Phthalate Metabolites Are Associated With Prevalent Diabetes in the Elderly , 2012, Diabetes Care.

[68]  S. Grundy.  Pre-diabetes, metabolic syndrome, and cardiovascular risk. , 2012, Journal of the American College of Cardiology.

[69]  Joachim Thiery,et al.  LC-MS-based metabolomics in the clinical laboratory. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[70]  S. Adams.  Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. , 2011, Advances in nutrition.

[71]  Lawrence Joseph,et al.  The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. , 2010, Journal of the American College of Cardiology.

[72]  Brett R. Wenner,et al.  Metabolomics Applied to Diabetes Research , 2009, Diabetes.

[73]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[74]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[75]  R Bethene Ervin,et al.  Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. , 2009, National health statistics reports.

[76]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.

[77]  Nigel W. Hardy,et al.  A roadmap for the establishment of standard data exchange structures for metabolomics , 2007, Metabolomics.

[78]  Nigel W. Hardy,et al.  Proposed minimum reporting standards for chemical analysis , 2007, Metabolomics.

[79]  C. Day.  Metabolic syndrome, or What you will: definitions and epidemiology , 2007, Diabetes & vascular disease research.

[80]  David W. Russell,et al.  LMSD: LIPID MAPS structure database , 2006, Nucleic Acids Res..

[81]  Douglas B. Kell,et al.  Statistical strategies for avoiding false discoveries in metabolomics and related experiments , 2007, Metabolomics.

[82]  E. Ford,et al.  Definition of the Metabolic Syndrome: What's New and What Predicts Risk? , 2006, Metabolic syndrome and related disorders.

[83]  J. Shaw,et al.  Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[84]  R. D'Agostino,et al.  Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus , 2005, Circulation.

[85]  C. Bouchard,et al.  Contribution of age and declining androgen levels to features of the metabolic syndrome in men. , 2005, Metabolism: clinical and experimental.

[86]  D. Mannino,et al.  Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. , 2004, Diabetes care.

[87]  S. Haffner,et al.  Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? , 2004, Diabetes care.

[88]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[89]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.